|
|
|
By Donatella Ballerini, GCP consultant | In today’s clinical trial landscape, where complexity is the new challenge, integration is not optional: QMS defines quality, and eTMF proves it. | |
|
|
|
| 7 Considerations For eCOA Technology Solutions | White Paper | By J.C. Wilson, IQVIA | Choosing the right vendor, solution, and deployment model is critical for a clinical trial to be successful. As a sponsor, consider these seven best practices when selecting the best eCOA. |
|
|
| Top 10 HEOR Trends | e-book | ISPOR—The Professional Society for Health Economics and Outcomes Research | This report outlines ten defining HEOR trends influencing global health decision-making. |
|
|
|
| Unlocking Potential AI And ML In Pharmacovigilance | Article | By Karthik Muthusamy, DIA | Artificial intelligence (AI) and machine learning (ML) hold transformative potential in pharmacovigilance (PV), with the ability to enhance the efficiency, accuracy, and timeliness of drug safety monitoring. |
|
|
| Waiver Of Consent vs Waiver Of Written Consent | Article | By Niecy Duncan, Castor | Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials. |
|
|
|
|
|
Tell Clinical Tech Leader how we can better support you in finding the right partners. Share your thoughts here. |
|
|
